Page last updated: 2024-08-26

nicotine and glyceryl 2-arachidonate

nicotine has been researched along with glyceryl 2-arachidonate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cascio, MG; Di Marzo, V; Fernández-Ruiz, J; Fezza, F; González, S; Ramos, JA1
Astarita, G; Caprioli, G; Ciccocioppo, R; Cippitelli, A; Duranti, A; Kallupi, M; Piomelli, D; Rodrìguez de Fonseca, F; Sagratini, G; Stopponi, S; Ubaldi, M1
Melis, M; Pistis, M1
Buczynski, MW; Chang, JW; Cravatt, BF; Herman, MA; Hsu, KL; Irimia, C; Natividad, LA; Niphakis, MJ; Parsons, LH; Polis, IY; Pugh, H; Roberto, M1
Berrendero, F; Busquets-Garcia, A; de la Torre, R; Di Marzo, V; Flores, Á; Maldonado, R; Marsicano, G; Ozaita, A; Pastor, A; Plaza-Zabala, A; Saravia, R1
Akinola, LS; Cravatt, BF; Damaj, MI; Lichtman, AH; Mahadevan, A; Muldoon, PP; Schlosburg, JE; Sim-Selley, LJ1

Reviews

1 review(s) available for nicotine and glyceryl 2-arachidonate

ArticleYear
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons.
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2012, Dec-05, Volume: 367, Issue:1607

    Topics: Animals; Arachidonic Acids; Dopamine; Dopaminergic Neurons; Endocannabinoids; Glycerides; Humans; Mesencephalon; Motivation; Nervous System Diseases; Nicotine; Receptor, Cannabinoid, CB1; Receptors, GABA; Reward; Substance-Related Disorders; Synaptic Transmission

2012

Other Studies

5 other study(ies) available for nicotine and glyceryl 2-arachidonate

ArticleYear
Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
    Brain research, 2002, Nov-01, Volume: 954, Issue:1

    Topics: Animals; Arachidonic Acids; Binding Sites; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cocaine; Endocannabinoids; Ethanol; Glycerides; In Situ Hybridization; Male; Nicotine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Substance-Related Disorders

2002
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid Receptor Modulators; Carbamates; Cotinine; Endocannabinoids; Glycerides; Implants, Experimental; Locomotion; Male; Maze Learning; Nicotine; Polyunsaturated Alkamides; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Weight Gain

2011
Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, Jan-26, Volume: 113, Issue:4

    Topics: Animals; Arachidonic Acids; Endocannabinoids; gamma-Aminobutyric Acid; Glycerides; Lipoprotein Lipase; Male; Nicotine; Rats; Rats, Wistar; Self Administration; Ventral Tegmental Area

2016
CB
    Biological psychiatry, 2017, 04-01, Volume: 81, Issue:7

    Topics: Animals; Arachidonic Acids; Brain; Cannabinoid Receptor Antagonists; Endocannabinoids; GABAergic Neurons; Glycerides; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Nicotine; Piperidines; Polyunsaturated Alkamides; Pyramidal Cells; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA; Recognition, Psychology; Rimonabant; Substance Withdrawal Syndrome

2017
Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
    Neuropharmacology, 2020, 10-01, Volume: 176

    Topics: Animals; Anti-Anxiety Agents; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Agonists; Conditioning, Classical; Endocannabinoids; Enzyme Inhibitors; Glycerides; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Monoacylglycerol Lipases; Nicotine; Piperidines; Receptor, Cannabinoid, CB1; Reward; Tobacco Use Disorder

2020